NCT02963779View on ClinicalTrials.gov

A Study of LY2775240 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

October 5, 2017

Study Completion Date

October 5, 2017

Conditions
Healthy
Interventions
DRUG

LY2775240

Administered orally

DRUG

Placebo

Administered orally

DRUG

Apremilast

Administered orally

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02963779 - A Study of LY2775240 in Healthy Participants | Biotech Hunter | Biotech Hunter